DMK
DMK Pharmaceuticals Corporation Common Stock
Delisted
DMK was delisted on the 6th of February, 2024.
58 hedge funds and large institutions have $18.7M invested in DMK Pharmaceuticals Corporation Common Stock in 2018 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 8 increasing their positions, 17 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
77% less call options, than puts
Call options by funds: $229K | Put options by funds: $975K
Holders
58
Holding in Top 10
–
Calls
$229K
Puts
$975K
Top Buyers
| 1 | +$254K | |
| 2 | +$167K | |
| 3 | +$110K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$108K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$75.2K |
Top Sellers
| 1 | -$3.36M | |
| 2 | -$1.29M | |
| 3 | -$1.19M | |
| 4 |
PA
Perceptive Advisors
New York
|
-$481K |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$346K |